vancomycin has been researched along with Kidney Diseases in 214 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (17.29) | 18.7374 |
| 1990's | 35 (16.36) | 18.2507 |
| 2000's | 37 (17.29) | 29.6817 |
| 2010's | 85 (39.72) | 24.3611 |
| 2020's | 20 (9.35) | 2.80 |
| Authors | Studies |
|---|---|
| Drusano, GL; Graves, J; Lodise, TP; Lomaestro, B | 1 |
| Becerir, T; Tokgün, O; Yuksel, S | 1 |
| Abo-Elmatty, DM; Hafez, MM; Khalaf, SS; Mehanna, ET; Mesbah, NM | 1 |
| Abo-Youssef, AM; Hassan, SM; Khalaf, MM; Sayed, AM | 1 |
| Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Al Segai, O; Hashem Ahmed, H; Husain Shaban, G; Malalla, Z; Saeed Tabbara, K; Sridharan, K | 1 |
| Daudon, M; Doreille, A; Letavernier, E; Luque, Y; Mesnard, L; Rafat, C; Zaworski, J | 1 |
| Stevens, JS; Stokes, MB | 1 |
| Fujii, S | 1 |
| Harris, VC; van Diemen, JJK; van Hest, RM; van Schip, AM | 1 |
| Alduhami, AA; ALharbi, A; Altowayan, WM; Mobark, MA; Rabbani, SI | 1 |
| Arai, T; Ishigami, A; Ishii, T; Kitano, T; Lee, J; Matsumoto, S; Mori, Y; Takigawa, M; Takino, Y; Tanaka, H; Yatsu, T | 1 |
| Avram, S; Dragic, S; Jovanovic, M; Kovacevic, P; Kovacevic, T; Miljkovic, B; Momcicevic, D; Vucicevic, K | 1 |
| Du, H; Li, X; Li, Z; Lin, Y; Wei, Y; Yang, Y; Zhuang, X | 1 |
| Alvarez, AS; Oyerinde, O; Reinert, JP | 1 |
| Bazin, D; Daudon, M; Dazzi, A; Deniset-Besseau, A; Esteve, E; Jouanneau, C; Luque, Y; Mesnard, L; Ronco, P; Waeytens, J | 1 |
| Ghaffari-Rafi, A; Miles, DT; Netzel, AC; Prat, M | 1 |
| Furuya, Y; Miyazaki, A; Murakami, Y; Nakashima, M; Nakashima, MN; Sakamoto, Y; Sanematsu, E; Shinohara, Y; Ueki, T | 1 |
| Nguyen, L; Yamaki, J | 1 |
| Dai, C; Hao, Z; Qu, S; Tang, Q; Wang, H; Wang, J; Zhao, H | 1 |
| Khalili, H; Rahmani, H | 1 |
| Hashiguchi, Y; Jono, H; Katanoda, T; Nakata, H; Oda, K; Saito, H | 1 |
| Capitano, B; El-Solh, AA; Liu, P; Stein, A | 1 |
| Imai, S; Iseki, K; Kasashi, K; Kobayashi, M; Yamada, T | 1 |
| Jeffres, MN | 1 |
| Liu, Y; Wang, J | 1 |
| Deresinski, S; Watkins, RR | 1 |
| Chuma, M; Imai, T; Kikuchi, N; Kinoshita, K; Komatsu, T; Kuwana, T; Makishima, M; Sakaue, T; Sawada, N; Suzuki, S; Tochikura, N; Yoshida, Y | 1 |
| Che, H; Gao, X; Shi, H; Wang, C; Wang, Y; Xue, C; Zhang, T; Zou, J | 1 |
| Dennehy, PH; Fiorito, TM; LaPlante, KL; Luther, MK; Matson, KL | 1 |
| In, YW; Kim, K; Kim, MJ; Lee, YM; Lim, NR; Park, HJ; Park, SJ; Yang, JW | 1 |
| Huo, X; Liu, K; Liu, Z; Ma, X; Meng, Q; Sun, H; Wang, C; Wen, S; Yang, S; Zhu, Y | 1 |
| Keller, F | 1 |
| Baba, H; Esaki, M; Hashimoto, H; Koido, K; Nakashima, T; Nishigaki, R; Okinaka, K; Otsuka, R; Otsuka, T; Sano, T; Terakado, H | 1 |
| Huang, M; Wu, H; Xu, M; Zhou, J; Zhou, S | 1 |
| Cabrera, MV; Castroagudin, A; di Fonzo, H; Mazzei, ME; Rueda, D; Villegas Gutsch, M | 1 |
| Canacankatan, N; Coskun Yilmaz, B; Guzel, S; Kibar, D; Uckun, Z; Yalaza, C | 1 |
| Imai, S; Iseki, K; Kasashi, K; Kobayashi, M; Niinuma, Y; Yamada, T | 1 |
| Barreto, EF; Barreto, JN; Rule, AD | 1 |
| Narita, I | 1 |
| Aguilar, L; Artero, A; Barberan, J; Calleja, JL; Epelde, F; Giménez, MJ; Granizo, JJ; Guerra, JM; Martínez-Gil, I; Mensa, J; Rodriguez, JC; Ruiz-Morales, J | 1 |
| Akashi, M; Hanada, K; Hirai, T; Itoh, T; Kanno, A | 1 |
| Ding, MX; Kiser, TH; Reilly, AM; Rower, JE | 1 |
| AlAnazi, L; AlFudail, S; AlMarzouq, F; Hakeam, HA; Mansour, R | 1 |
| Joyce, EL; Kane-Gill, SL; Kellum, JA; Ostermann, M; Shi, J | 1 |
| Avedissian, SN; Chang, J; Griffin, B; Gulati, A; Hlukhenka, K; Joshi, MD; Lamar, PC; Pais, GM; Prozialeck, WC; Scheetz, MH; Zhang, Z | 1 |
| Chiletti, R; Cranswick, N; Curtis, N; Gwee, A; Sosnin, N | 1 |
| Alvarez, CA; Bedimo, RJ; Bell, T; Brouse, SD; Forcade, NA; Frei, CR; Giuliano, CA; Haase, KK; Hall, RG; Hazlewood, KA | 1 |
| Cies, JJ; Shankar, V | 1 |
| Ampe, E; Delaere, B; Glupczynski, Y; Hecq, JD; Tulkens, PM | 1 |
| Iga, I; Konishi, H; Mizumura, M; Morita, Y; Nagai, K | 1 |
| Feng, C; Fullmer, A; McCue, D | 1 |
| Chavanet, P | 1 |
| An, H; Cho, SH; Han, HK; Jang, IJ; Kang, HR; Kim, JH; Lee, SH; Lim, KS; Shin, D; Shin, KH; Yu, KS | 1 |
| Chen, Y; Fang, Y; Long, R; Meng, L; Zhu, H | 1 |
| Hynicka, LM; Meaney, CJ; Tsoukleris, MG | 1 |
| File, TM; Ford, KD; Kelley, R; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Stein, GE; Welch, V; Wiemken, TL; Zervos, MJ | 1 |
| Bookstaver, PB; Justo, JA | 1 |
| Du, P; Farag, H; Kheir, F; Kong, L; Moh'd, H; Mohamad, A; Zurlo, JJ | 1 |
| Aberle, C; Brumer, E; Dubrovskaya, Y; Papadopoulos, J; Rahimian, J; Scipione, MR | 1 |
| Alvarez, CA; Bedimo, RJ; Bell, T; Blaszczyk, AT; Brouse, SD; Forcade, NA; Frei, CR; Giuliano, CA; Hall, RG; Mortensen, EM; Thompson, KA | 1 |
| Boyce, TG; Yock, LC | 1 |
| Carreno, JJ; Kenney, RM; Lomaestro, B | 1 |
| Borton, AR; Mergenhagen, KA | 1 |
| Hiramatsu, K; Itoh, H; Kadota, J; Kohno, K; Morinaga, Y; Ogata, M; Sato, Y; Suzuki, Y; Takano, K; Tokimatsu, I | 1 |
| Dashti-Khavidaki, S; Elyasi, S; Emadi-Koochak, H; Khalili, H | 1 |
| Haruki, Y; Komoto, A; Kondo, S; Maiguma, T; Masuda, N; Sugiyama, T; Teshima, D | 1 |
| Beck, GL; Matson, KL; Shaffer, CL; Simonsen, KA | 1 |
| DeGrado, JR; Kubiak, DW; Labonville, S; Marquis, KA; Szumita, PM | 1 |
| Berselli, A; Bertacchini, S; Capuzzo, M; Fogagnolo, A; Marangoni, E; Ragazzi, R; Spadaro, S; Volta, CA | 1 |
| Chen, BY; Dong, MH; Wang, JW; Wen, AD; Wu, Y; Yu, M | 1 |
| Cava, L; Goolsby, TA; Hong, LT; Kiser, TH; Mueller, SW; Neumann, R; Reynolds, P; Sherman, DS | 1 |
| Arrabal-Durán, P; Hidalgo-Collazos, P; López González-Cobos, C; Sanjurjo-Sáez, M | 1 |
| Anguita, P; Cobo Reinoso, J; Gani, R; Grau Cerrato, S; Mensa Pueyo, J; Rubio-Rodríguez, D; Rubio-Terrés, C; Salavert Lletí, M; Toledo, A; Watt, M | 1 |
| Edwards, D; Maliske, SM; Suneja, M | 1 |
| Bradley, J; Capparelli, E; Lane, J; Le, J; Muus, R; Ngu, B; Ny, P; Romanowski, G; Vo, T | 1 |
| Chen, H; Hao, JJ; Zhou, JX | 1 |
| Arnold, R; Comer, D; Davis, JJ; Levine, BJ; Muenzer, J; Papas, MA; Rosini, JM | 1 |
| Downes, KJ; Goldstein, SL; Vinks, AA | 1 |
| Chen, EZ; He, J; Jiang, HT; Jing, F; Mao, EQ; Yang, WH | 1 |
| Abu-Kishk, I; Bahat, H; Berkovitch, M; Dagan, Z; Goldman, M; Klin, B; Kozer, E; Sabler, IM; Sandbank, J; Stav, K; Zisman, A | 1 |
| Chu, Y; Jiang, M; Luo, Y; Qu, L; Zhao, C | 1 |
| Cheng, DH; Liu, TT; Lu, H; Qin, XL; Wei, WX | 1 |
| Mellen, CK; Rindone, JP; Ryba, JE | 1 |
| Barber, KE; Bell, AM; Stover, KR; Wagner, JL | 1 |
| Bazin, D; Boueilh, A; Burbach, M; Daudon, M; Esteve, E; Frère, P; Frochot, V; Gosset, C; Jouanneau, C; Langui, D; Letavernier, E; Louis, K; Luque, Y; Mesnard, L; Placier, S; Rondeau, E; Vandermeersch, S; Verpont, MC; Wolfromm, A | 1 |
| Stokes, MB | 1 |
| Edwards, C; Natarajan, S; Roth, V; Zvonar, R | 1 |
| Hsueh, PR; Huang, YT; Kuo, CC; Liao, CH; Wu, VC | 1 |
| Aiba, T; Izuwa, Y; Kawasaki, H; Kurosaki, Y; Okazaki, M; Sato, T; Sendo, T; Ueshima, S | 1 |
| Dieterich, C; Fairchild, D; Furimsky, A; Lin, S; Lyn, S; Mirsalis, JC; Ng, HH; Puey, A; Swezey, R | 1 |
| Hiraki, Y; Kamimura, H; Karube, Y; Mizoguchi, A; Sadoh, S; Sonemoto, E; Tsuji, Y | 1 |
| Drusano, GL; Lodise, TP; Lomaestro, BM; Patel, N; Rodvold, KA | 1 |
| Asner, S; Buclin, T; Calandra, T; Erard, V; Lamoth, F; Marchetti, O | 1 |
| Hutschala, D; Kinstner, C; Müller, M; Skhirdladze, K; Thalhammer, F; Tschernko, E | 1 |
| Aksoy, NH; Baykal, A; Celik-Ozenci, C; Dalaklioglu, S; Gungor, NE; Tasatargil, A; Tekcan, M | 1 |
| Florescu, MC; Hanson, M; Hermsen, ED; Rupp, ME; Sankaranarayanan, J; Stoner, JA | 1 |
| Brouse, SD; Hall, RG; Hazlewood, KA; Pitcher, WD | 1 |
| Nolin, TD; Weiner, DE | 1 |
| Ahmida, MH | 1 |
| Badami, K; Downing, J; Frizelle, F; Ganly, P; Stiven, P | 1 |
| Hewton, C; Jones, TE; Vasileff, H | 1 |
| Aubron, C; Cheng, AC; Corallo, CE; Dooley, MJ; Nunn, MO; Poole, S | 1 |
| Bookstaver, PB; Bosso, JA; Mauldin, PD; Nappi, J; Rudisill, C; Swindler, J; Wellein, M | 1 |
| Alfandari, S; Berthon, C; Cliquennois, M; Corm, S; Gay, J; Hochart, C; Tricot, S | 1 |
| Lenoble, M | 1 |
| Cano, EL; Cely, CM; Ford, KD; Haque, NZ; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Welch, VL; Zervos, MJ | 1 |
| Dashti-Khavidaki, S; Elyasi, S; Khalili, H; Mohammadpour, A | 1 |
| Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
| Hisaka, A; Suzuki, H; Terakawa, H; Yamamoto, T | 1 |
| Czasch, S; Emde, B; Frick, K; Fuchs, TC; Hewitt, P; von Landenberg, F | 1 |
| Glowacki, RC; Itokazu, GS; Rezai, K; Rodvold, KA; Schwartz, DN; Teng, CB; Weinstein, RA; Xamplas, RC | 1 |
| Alexander, DP; DeRyke, CA; Reynolds, DC; Waite, LH | 1 |
| Dashti-Khavidaki, S; Elyasi, S; Hatamkhani, S; Khalili, H | 1 |
| Horey, A; Mattappallil, A; Mergenhagen, KA | 1 |
| Claude, D; Corvaisier, S; Ducher, M; Jelliffe, R; Maire, P; Maurin, M; Rougier, F; Sedoglavic, A | 1 |
| Darko, W; Guharoy, R; Lehmann, DE; Medicis, JJ; Smith, A | 1 |
| CARSON, NA; WALLACE, IR | 1 |
| BARBER, M | 1 |
| de Hoog, M; Mouton, JW; van den Anker, JN | 1 |
| Wunderink, RG | 1 |
| Furuta, I; Kitahashi, T | 1 |
| Arslan, MK; Candir, O; Ciris, M; Oktem, F; Ozguner, F; Uz, E; Yilmaz, HR | 1 |
| Matsuyama, K; Nishikata, M; Okamoto, K; Uchida, T; Yasuda, N; Yoshida, M | 1 |
| Akbulut, HH; Akpolat, N; Celik, I; Cihangiroglu, M; Ilhan, N | 1 |
| Bergamasco, S; Donadio, C; Malacarne, P | 1 |
| Abdulkader, RC; Colares, VS; Oliveira, RB | 1 |
| Ghafghazi, T; Hajhashemi, V; Naghibi, B; Taheri, D; Talebi, A | 1 |
| Andronikou, SK; Giapros, VI; Papadimitriou, FK | 1 |
| Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
| Barraclough, K; Harris, M; Levin, A; Montessori, V | 1 |
| Doherty, JA; Isakow, W; Jeffres, MN; Kollef, MH; Micek, ST | 1 |
| Kollef, MH | 1 |
| Aslan, C; Cetin, H; Ciris, M; Oktem, F; Olgar, S; Ozguner, F; Uz, E | 1 |
| Chen, CY; Chiou, YH; Su, YT; Wang, JS; Wu, CY | 1 |
| Hodoshima, N; Inui, K; Masuda, S | 1 |
| Fielden, MR; Gu, YZ; Smith, RJ; Snyder, RD; Wang, EJ | 1 |
| Asano, S; Hongo, E; Kasahara, S; Kato, S; Konuma, T; Kurokawa, Y; Mae, H; Oiwa-Monna, M; Ooi, J; Takahashi, S; Tojo, A; Tomonari, A; Tsukada, N | 1 |
| Harrison, EF; Zygmunt, WA | 1 |
| Greenblatt, DJ; Krogstad, DJ; Moellering, RC | 1 |
| Moellering, RC | 1 |
| McCracken, GH; Nelson, JD; Odio, C | 1 |
| Halstenson, CE; Keane, WF; Matzke, GR; McGory, RW | 1 |
| Mirahmadi, MK; Vaziri, ND | 1 |
| Pryka, RD | 1 |
| Aubertin, J; Brunet, F; Charbonneau, P; Domart, Y; Garaud, JJ; Harding, I | 1 |
| McCall, BA | 1 |
| Begg, EJ; Duffull, SB | 2 |
| Fitzgerald, CM; Gilliland, SS; Guay, DR; Rodvold, KA; Rotschafer, JC; Vance-Bryan, K | 1 |
| Capeyron, O; Demotes-Mainard, F; Dupon, M; Janvier, G; Saric, J; Vinçon, G; Winnock, S | 1 |
| Goetz, MB; Sayers, J | 1 |
| Freeman, CD; Nightingale, CH; Quintiliani, R | 1 |
| Chow, AW; Jewesson, PJ; Kureishi, A; Phillips, GL | 1 |
| Dembry, LM; Uzokwe, K; Zervos, MJ | 1 |
| Cobo, J | 1 |
| Caballero, D; Calvo, MV; Domínguez-Gil, A; Fernández de Gatta, MD; Hernández, JM; San Miguel, JF | 1 |
| Bowhay, S; Timms, P | 1 |
| Borner, K; Eckhardt, A; Keller, F; Zellner, D | 1 |
| Janicka, L; Janicki, K; Ksiazek, A; Solski, J | 1 |
| Hosoya, J; Nakagawa, Y; Takahashi, S; Toyoguchi, T; Watanabe, H | 1 |
| Appleton, D | 2 |
| Demitrovicova, A; Grausova, S; Halko, J; Koren, P; Kralovicová, K; Krcmery, V; Krupova, I; Kukuckova, E; Netriova, J; Novotny, J; Spanik, S; Studena-Mrazova, M | 1 |
| Avers, RJ; Azzazy, HM; Chiappetta, E; Chou, PP; Christenson, RH; Duh, SH; Gordon, M; Troxil, S; Tsushima, JH | 1 |
| Aboleneen, HI; Backes, DW; Simpson, JA | 1 |
| Frankewitsch, T; Keller, F; Zellner, D | 1 |
| Amyes, SG; Brown, AR; Miles, RS; Paton, R; Plant, WD; Stevenson, GM; Winney, RJ | 1 |
| Bruton, J; Champlin, R; Ippoliti, C; Van Besien, K; Warkentin, D | 1 |
| Abbott, M; Aberline, M; Grabsch, EA; Grayson, ML; Hogg, G; Johnson, PD; Kerr, PG; Li, HY; Olden, D | 1 |
| Ben Abid, H; Hadj Ali, ZB; Hafsia, A; Kaufman, L; Lauwers, S; Meddeb, B; Schots, R; Trullemans, F; Van Camp, B; Van Riet, I | 1 |
| Hirono, S; Kobayashi, H; Orii, T; Tanaka, M | 1 |
| Gouin, F; Pham Dang, C; Potel, G; Richard, C; Touchais, S | 1 |
| Oguma, T; Ohnishi, A; Shimamura, K; Yano, Y | 1 |
| Beauchamp, D; Kanke, M; Wong, PC; Yazaki, T; Yoshiyama, Y | 1 |
| Hoaglund, PA; McKinnon, PS; Mozaffari, E; Nolet, B; Tice, AD | 1 |
| Blum, R; Seymour, JF; Toner, G | 1 |
| Appel, GB; Neu, HC | 1 |
| Eichenwald, HF; McCracken, GH | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Brent, J; Burkhart, KK; Kulig, K; Metcalf, S; O'Meara, O; Rumack, BH; Shurnas, E | 1 |
| Davey, PG; Williams, AH | 1 |
| Chow, AW; Cole, CD; Jewesson, PJ; Kureishi, A; Phillips, GL; Reece, DE; Rubinger, M; Smith, JA | 1 |
| Pachorek, RE; Wood, F | 1 |
| Beauchamp, D; Bergeron, MG; Gourde, P; Pellerin, M; Pettigrew, M | 1 |
| Forbes, A; Murray-Lyon, I | 1 |
| Anne, L; Forni, T; Gottwald, K; Hu, MW | 1 |
| Albrecht, LM; Boike, SC; Chandrasekar, PH; Rybak, MJ | 1 |
| Collins, CH; Fitch, LE; George, RC; Gilfillan, AJ; Heptonstall, J; Johnson, AP; Morrison, D; Naidoo, J; Uttley, AH; Woodford, N | 1 |
| Gudmundsson, GH; Jensen, LJ | 1 |
| Coullioud, D; Flandrois, C; Flandrois, JP; Maire, I | 1 |
| Baker, DK; Goren, MP; Shenep, JL | 1 |
| Anne, L; Chan, K; Colin, L; Gottwald, K; Hu, M | 1 |
| Cabinian, AE; Ostrea, EM; Reyes, MP; Rintelmann, W; Schmitt, C | 1 |
| Albridge, K; Flexner, JM; Lenox, RK; Ray, W; Stein, RS | 1 |
| Blum, RA; Crossley, KB; Fischer, JH; Riff, LJ; Rodvold, KA; Rotschafer, JC; Zokufa, HZ | 1 |
| Appel, GB; Cooper, GL; Given, DB; Levine, LR | 1 |
| Comstock, TJ; Garson, ML; Healy, DP; Polk, RE; Rock, DT | 1 |
| Nahata, MC | 1 |
| Edwards, DJ; Pancorbo, S | 1 |
| Gilbert, DN; Houghton, DC; Kohlhepp, SJ; Kohnen, PW; Wood, CA | 1 |
| Collins, AJ; Keshaviah, PR; Matzke, GR; O'Connell, MB | 1 |
| Rudd, CC; Swinney, VR | 1 |
| Cuevas, R; Gorbea, HF; Ramírez-Ronda, CH; Sánchez, J | 1 |
| Collignon, PJ; Sorrell, TC | 1 |
| Dean, RP; Tolpin, MD; Wagner, DJ | 1 |
| Hubmann, R | 1 |
| Kovnat, P; Labovitz, E; Levison, SP | 1 |
| Johnson, AH | 1 |
| Bulger, RJ; Feigl, P; Nielson, K | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Fomina, IP; Lobuseva, AN | 1 |
| Reubi, F | 1 |
| Hitzenberger, G | 1 |
| Lindholm, DD; Murray, JS | 1 |
34 review(s) available for vancomycin and Kidney Diseases
| Article | Year |
|---|---|
Prevention of Vancomycin-Induced Nephrotoxicity; An Updated Review of Clinical and Preclinical Studies.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Humans; Kidney Diseases; Renal Insufficiency; Silymarin; Vancomycin | 2022 |
The Whole Price of Vancomycin: Toxicities, Troughs, and Time.
Topics: Anti-Bacterial Agents; Health Care Costs; Humans; Incidence; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2017 |
A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Humans; Kidney Diseases; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Child; Humans; Intensive Care Units; Kidney; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2018 |
[Pharmacotherapy and kidney dysfunction].
Topics: Anti-Bacterial Agents; Critical Illness; Glomerular Filtration Rate; Humans; Kidney Diseases; Meropenem; Pharmacokinetics; Piperacillin; Vancomycin | 2019 |
Agranulocytosis Induced by Vancomycin. Case Report and Literature Review.
Topics: Abdominal Abscess; Adult; Agranulocytosis; Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Endocarditis, Bacterial; Granulocyte Colony-Stimulating Factor; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Urinary Tract Infections; Vancomycin | 2018 |
High versus low vancomycin serum trough regimen for Gram-positive infections: a meta-analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Middle Aged; Prospective Studies; Retrospective Studies; Vancomycin | 2015 |
Vancomycin-associated renal dysfunction: where are we now?
Topics: Anti-Bacterial Agents; Humans; Kidney Diseases; Vancomycin | 2014 |
Vancomycin nephrotoxicity: a review.
Topics: Anti-Bacterial Agents; Humans; Kidney Diseases; Risk Factors; Vancomycin | 2014 |
Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis.
Topics: Adult; Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Infusions, Intravenous; Kidney Diseases; Treatment Outcome; Vancomycin | 2016 |
Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kidney Diseases; Observational Studies as Topic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Retrospective Studies; Vancomycin | 2017 |
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Humans; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2016 |
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
[Treatment of resistant Gram-positive bacterial infections].
Topics: Animals; Anti-Bacterial Agents; Catheter-Related Infections; Cloxacillin; Daptomycin; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Rats; Staphylococcal Infections; Vancomycin | 2011 |
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Incidence; Infant; Infant, Newborn; Kidney; Kidney Diseases; Male; Oxidative Stress; Pregnancy; Risk Assessment; Risk Factors; Time Factors; Vancomycin | 2012 |
Prevention of vancomycin induced nephrotoxicity: a review of preclinical data.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Kidney Diseases; Tissue Distribution; Vancomycin | 2013 |
Vancomycin: pharmacokinetics and administration regimens in neonates.
Topics: Adult; Aging; Animals; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; Gestational Age; Half-Life; Humans; Infant, Newborn; Kidney Diseases; Metabolic Clearance Rate; Tinnitus; Tissue Distribution; Vancomycin | 2004 |
[Stakes, treatment strategies and progression of MRSA nosocomial pneumonia, especially pneumonia due to mechanical ventilation].
Topics: Acute Disease; Anti-Bacterial Agents; Critical Care; Cross Infection; Disease Progression; Drug Monitoring; Hospital Mortality; Humans; Kidney Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Patient Selection; Pneumonia, Bacterial; Prognosis; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2004 |
[Glycopeptides (vancomycin, teicoplanin)].
Topics: Anti-Bacterial Agents; Biomarkers; Chromatography, High Pressure Liquid; Drug Monitoring; Electrophoresis, Capillary; Humans; Kidney Diseases; Reference Values; Specimen Handling; Teicoplanin; Vancomycin | 2004 |
Limitations of vancomycin in the management of resistant staphylococcal infections.
Topics: Anti-Bacterial Agents; Humans; Kidney Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review.
Topics: Adolescent; Anti-Bacterial Agents; Humans; Kidney Diseases; Kidney Tubules; Lupus Nephritis; Male; Necrosis; Vancomycin | 2007 |
Pharmacokinetics of vancomycin.
Topics: Adult; Animals; Body Fluids; Cats; Female; Half-Life; Humans; Intestinal Absorption; Kidney Diseases; Kidney Function Tests; Kinetics; Rabbits; Rats; Tissue Distribution; Vancomycin | 1984 |
Vancomycin toxicity. What is the evidence for dose dependency?
Topics: Dose-Response Relationship, Drug; Ear Diseases; Ear, Inner; Humans; Hypotension; Kidney Diseases; Vancomycin | 1994 |
Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination.
Topics: Aged; Aged, 80 and over; Amikacin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Vancomycin | 1993 |
Vancomycin therapeutic drug monitoring: is it necessary?
Topics: Animals; Bacterial Infections; Child, Preschool; Drug Monitoring; Ear Diseases; Humans; Infant; Infant, Newborn; Kidney Diseases; Vancomycin | 1993 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
[Vancomycin and teicoplanin: differential aspects].
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythema; Gram-Positive Bacterial Infections; Hearing Loss; Humans; Incidence; Infusions, Intravenous; Kidney Diseases; Prospective Studies; Teicoplanin; Vancomycin | 1995 |
Nursing management of renal inpatients with antibiotic-resistant bacteria--VRE.
Topics: Bacterial Infections; Drug Resistance, Microbial; Education, Nursing, Continuing; Humans; Infection Control; Kidney Diseases; Vancomycin | 1997 |
Antimicrobial therapy in infants and children. Part I. Review of antimicrobial agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacitracin; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Clindamycin; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Infant; Kidney Diseases; Lincomycin; Nalidixic Acid; Nitrofurans; Oxolinic Acid; Penicillin Resistance; Penicillins; Polymyxins; Rifampin; Sulfamethoxazole; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1978 |
A review of the safety profile of teicoplanin.
Topics: Animals; Anti-Bacterial Agents; Drug Hypersensitivity; Ear Diseases; Glycopeptides; Humans; Kidney Diseases; Safety; Skin Diseases; Teicoplanin; Vancomycin | 1991 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Vancomycin and the kidney.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Half-Life; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Kinetics; Nephrectomy; Renal Dialysis; Vancomycin | 1986 |
Antibiotics and the kidney.
Topics: Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Gentamicins; Humans; Kanamycin; Kidney; Kidney Diseases; Neomycin; Penicillins; Polymyxins; Regional Blood Flow; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1973 |
Adverse effects of antibiotics.
Topics: Aminoglycosides; Ampicillin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Carbenicillin; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Dermatitis; Drug Hypersensitivity; Gentamicins; Humans; Kanamycin; Kidney Diseases; Lincomycin; Neomycin; Penicillins; Polymyxins; Streptomycin; Tetracycline; Vancomycin | 1972 |
21 trial(s) available for vancomycin and Kidney Diseases
| Article | Year |
|---|---|
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.
Topics: Acetamides; Anti-Bacterial Agents; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Incidence; Kidney; Kidney Diseases; Linezolid; Male; Middle Aged; Oxazolidinones; Vancomycin | 2008 |
Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Kidney Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult | 2014 |
A retrospective analysis to estimate target trough concentration of vancomycin for febrile neutropenia in patients with hematological malignancy.
Topics: Adult; Aged; Drug Monitoring; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; ROC Curve; Treatment Outcome; Vancomycin | 2015 |
Conventional- versus high-dose vancomycin regimen in patients with acute bacterial meningitis: a randomized clinical trial.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Meningitis, Bacterial; Middle Aged; Vancomycin | 2015 |
Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Care; Female; Humans; Infusions, Intravenous; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2015 |
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Cross Infection; Female; Hospitals; Humans; Incidence; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Prospective Studies; South Carolina; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.
Topics: Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Monitoring; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Netilmicin; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Cost-Benefit Analysis; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Male; Middle Aged; Prospective Studies; Vancomycin | 1996 |
Influence of intraperitoneal vancomycin on peritoneal dialysis efficiency. A clinical study.
Topics: Adult; Aged; Cell Membrane Permeability; Creatinine; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis; Peritoneum; Potassium; Prospective Studies; Ultrafiltration; Urea; Vancomycin | 1997 |
Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Diseases; Neoplasms; Neutropenia; Risk Factors; Slovakia; Vancomycin | 1997 |
Synthesis of pharmacokinetic parameters of vancomycin via bootstrap methods.
Topics: Adult; Aged; Algorithms; Anti-Bacterial Agents; Data Interpretation, Statistical; Half-Life; Humans; Kidney Diseases; Kidney Function Tests; Middle Aged; Vancomycin | 1998 |
[The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Catheterization, Central Venous; Chronic Disease; Drug Costs; Drug Hypersensitivity; Female; France; Health Care Costs; Humans; Infusions, Intravenous; Kidney Diseases; Male; Methicillin Resistance; Middle Aged; Osteitis; Phlebitis; Pneumothorax; Postoperative Complications; Prospective Studies; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Syndrome; Teicoplanin; Vancomycin | 2001 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
A review of the safety profile of teicoplanin.
Topics: Animals; Anti-Bacterial Agents; Drug Hypersensitivity; Ear Diseases; Glycopeptides; Humans; Kidney Diseases; Safety; Skin Diseases; Teicoplanin; Vancomycin | 1991 |
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclosporine; Double-Blind Method; Drug Interactions; Female; Fever; Glycopeptides; Humans; Kidney Diseases; Male; Middle Aged; Neutropenia; Piperacillin; Teicoplanin; Tobramycin; Vancomycin | 1991 |
Vancomycin and nephrotoxicity.
Topics: Clinical Trials as Topic; Creatinine; Drug Administration Schedule; Humans; Kidney Diseases; Random Allocation; Vancomycin | 1989 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Kidney Diseases; Male; Monitoring, Physiologic; Vancomycin | 1987 |
162 other study(ies) available for vancomycin and Kidney Diseases
| Article | Year |
|---|---|
The therapeutic effect of Cilastatin on drug-induced nephrotoxicity: a new perspective.
Topics: Apoptosis; Cell Line; Cell Survival; Cilastatin; Cisplatin; Dose-Response Relationship, Drug; Gentamicins; HEK293 Cells; Hepatitis A Virus Cellular Receptor 1; Humans; Inhibitory Concentration 50; Kidney Diseases; Lipocalin-2; Oxidative Stress; Vancomycin | 2021 |
Anti-oxidant, anti-apoptotic, and mitochondrial regulatory effects of selenium nanoparticles against vancomycin induced nephrotoxicity in experimental rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Gene Expression Regulation; Kidney Diseases; Male; Mitochondria; Nanoparticles; Rats; Rats, Wistar; Selenium; Vancomycin | 2022 |
Ameliorate impacts of scopoletin against vancomycin-induced intoxication in rat model through modulation of Keap1-Nrf2/HO-1 and IκBα-P65 NF-κB/P38 MAPK signaling pathways: Molecular study, molecular docking evidence and network pharmacology analysis.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Heme Oxygenase (Decyclizing); Kelch-Like ECH-Associated Protein 1; Kidney; Kidney Diseases; Male; NF-E2-Related Factor 2; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Protective Agents; Rats, Wistar; Scopoletin; Signal Transduction; Transcription Factor RelA; Vancomycin | 2022 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A Virus Cellular Receptor 1; Humans; Ibuprofen; Infant, Newborn; Kidney Diseases; Lipocalin-2; Male; Middle Aged; Vancomycin | 2021 |
Noninvasive screening of vancomycin-associated cast nephropathy.
Topics: Humans; Immunoglobulin Light Chains; Kidney Diseases; Multiple Myeloma; Vancomycin | 2022 |
Vancomycin-Associated Cast Nephropathy: Reality or Fantasy?
Topics: Fantasy; Humans; Kidney; Kidney Diseases; Vancomycin | 2022 |
[Antimicrobial Stewardship Initiatives and Studies by the Hospital Pharmacist: Study of Linezolid-associated Thrombocytopenia].
Topics: Antimicrobial Stewardship; Hospitals; Humans; Kidney Diseases; Linezolid; Pharmacists; Retrospective Studies; Thrombocytopenia; Vancomycin | 2022 |
An Unusual Case of Low Vancomycin Exposure Despite Extremely High Vancomycin Doses Accompanied by Renal Toxicity: A Grand Round.
Topics: Anti-Bacterial Agents; Humans; Kidney; Kidney Diseases; Teaching Rounds; Vancomycin | 2023 |
The influence of vancomycin on renal functions, the predictors and associated factors for nephrotoxicity.
Topics: Anti-Bacterial Agents; Creatinine; Cross-Sectional Studies; Female; Humans; Kidney; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Renal Insufficiency; Retrospective Studies; Urea; Vancomycin | 2023 |
High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Injections, Intraperitoneal; Kidney; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidative Stress; Staphylococcal Infections; Vancomycin | 2019 |
Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Drug Administration Schedule; Drug Monitoring; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies; Sepsis; Vancomycin; Young Adult | 2020 |
New insights into the vancomycin-induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling.
Topics: Adult; Anti-Bacterial Agents; Cells, Cultured; Female; Humans; Kidney; Kidney Diseases; Kidney Tubules; Male; Metabolomics; Models, Animal; Toxicity Tests; Vancomycin; Young Adult | 2020 |
Drug-Induced Kidney Disease Associated With Selected Antibiotics.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Kidney Diseases; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2020 |
Nanometric Chemical Speciation of Abnormal Deposits in Kidney Biopsy: Infrared-Nanospectroscopy Reveals Heterogeneities within Vancomycin Casts.
Topics: Biopsy; Humans; Kidney Diseases; Microscopy, Electron, Scanning; Nanoparticles; Spectrophotometry, Infrared; Vancomycin | 2020 |
Cerebellar Parieto-occipital Posterior Reversible Encephalopathy Syndrome and Cerebral Metamorphopsia Associated with Asymptomatic Atrial Septum Vegetation and Renal Disease: Case Report.
Topics: Adult; Anti-Bacterial Agents; Antihypertensive Agents; Ceftazidime; Cerebrospinal Fluid Shunts; Diagnosis, Differential; Dialysis; Endocarditis, Subacute Bacterial; Female; Humans; Hypertension; Kidney Diseases; Posterior Leukoencephalopathy Syndrome; Vancomycin; Vasodilator Agents; Vision Disorders | 2020 |
Relationship between vancomycin-associated nephrotoxicity and the number of combined nephrotoxic agents.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Urea Nitrogen; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin | 2020 |
A brief evaluation of vancomycin loading doses and nephrotoxicity in the elderly population.
Topics: Aged; Anti-Bacterial Agents; Humans; Kidney Diseases; Retrospective Studies; Vancomycin | 2020 |
Chlorogenic acid prevents vancomycin-induced nephrotoxicity without compromising vancomycin antibacterial properties.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Chlorogenic Acid; Cytoprotection; Kidney; Kidney Diseases; Male; Microbial Sensitivity Tests; Oxidative Stress; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2020 |
Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2021 |
Usefulness of a decision tree model for the analysis of adverse drug reactions: Evaluation of a risk prediction model of vancomycin-associated nephrotoxicity constructed using a data mining procedure.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Creatinine; Data Mining; Decision Trees; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Assessment; Vancomycin; Young Adult | 2017 |
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?
Topics: Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Vancomycin | 2017 |
Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients.
Topics: Aged; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Female; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin | 2018 |
Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Docosahexaenoic Acids; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Oxidative Stress; Phosphatidylcholines; Protective Agents; Vancomycin | 2018 |
Evaluation of risk factors for vancomycin-induced nephrotoxicity.
Topics: Aged; Anti-Bacterial Agents; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Vancomycin | 2018 |
JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Cytoprotection; Disease Models, Animal; Gene Expression Regulation; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 2; Oxidative Stress; Peptides, Cyclic; Rats, Wistar; Renal Elimination; Vancomycin | 2018 |
Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Pharmacists; Pharmacy Service, Hospital; Professional Role; Retrospective Studies; Specialization; Vancomycin | 2018 |
Efficacy of Vancomycin on Gram-Positive Bacterial Infection in Elderly Critical Patients and Risk Factors Associated With Nephrotoxicity.
Topics: Aged, 80 and over; Anti-Bacterial Agents; APACHE; China; Creatinine; Critical Illness; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Kidney Diseases; Logistic Models; Male; Multivariate Analysis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Vancomycin | 2018 |
Potential protective effects of naringenin against vancomycin-induced nephrotoxicity via reduction on apoptotic and oxidative stress markers in rats.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Dose-Response Relationship, Drug; Flavanones; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Vancomycin | 2020 |
Construction of a risk prediction model of vancomycin-associated nephrotoxicity to be used at the time of initial therapeutic drug monitoring: A data mining analysis using a decision tree model.
Topics: Aged; Anti-Bacterial Agents; Data Mining; Decision Trees; Drug Monitoring; Female; Humans; Japan; Kidney Diseases; Male; Middle Aged; Models, Statistical; Prognosis; Retrospective Studies; Risk Assessment; Vancomycin | 2019 |
Navigating the Muddy Waters of Vancomycin Nephrotoxicity.
Topics: Anti-Bacterial Agents; Humans; Kidney Diseases; Prognosis; Risk Factors; Vancomycin | 2019 |
[Drug-induced kidney injury due to antibiotic agents].
Topics: Anti-Bacterial Agents; Humans; Kidney Diseases; Vancomycin | 2016 |
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Glomerular Filtration Rate; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Diuretics; Drug Interactions; Drug Monitoring; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Topics: Aging; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Kidney Diseases; Retrospective Studies; Vancomycin | 2019 |
Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study.
Topics: Adult; Aged; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies; Vancomycin | 2019 |
Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.
Topics: Anti-Bacterial Agents; Biomarkers; Critical Illness; Drug Therapy, Combination; Humans; Kidney Diseases; Piperacillin, Tazobactam Drug Combination; Vancomycin | 2019 |
Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.
Topics: Animals; Animals, Newborn; Body Weight; Female; Fetus; Kidney; Kidney Diseases; Placenta; Pregnancy; Prenatal Care; Rats; Rats, Sprague-Dawley; Vancomycin | 2019 |
Vancomycin is commonly under-dosed in critically ill children and neonates.
Topics: Administration, Intravenous; Adolescent; Age Factors; Anti-Bacterial Agents; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Monitoring; Female; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Kidney Diseases; Male; Medical Records; Retrospective Studies; Sepsis; Vancomycin | 2019 |
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Body Weight; Female; Hospitals; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Staphylococcal Infections; Vancomycin | 2013 |
Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Kidney Diseases; Male; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2013 |
Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Serum; Vancomycin | 2013 |
Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
Topics: Animals; Creatinine; Drug Administration Schedule; Kidney; Kidney Diseases; Male; Random Allocation; Rats; Rats, Wistar; Superoxide Dismutase; Vancomycin | 2013 |
Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
Topics: Acyclovir; Administration, Intravenous; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Female; Humans; Kidney Diseases; Leukemia; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Vancomycin | 2014 |
Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Kidney Diseases; Male; Middle Aged; Odds Ratio; Risk Factors; Vancomycin | 2014 |
Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.
Topics: Acetamides; Adult; Anemia; Anti-Bacterial Agents; APACHE; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2014 |
Commentary on "incidence and predictors of vancomycin-associated nephrotoxicity".
Topics: Anti-Bacterial Agents; Female; Humans; Kidney Diseases; Male; Vancomycin | 2014 |
Incidence and predictors of vancomycin-associated nephrotoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Vancomycin | 2014 |
Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.
Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Female; Humans; Kidney Diseases; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Shock, Septic; Vancomycin; Young Adult | 2015 |
Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Body Weight; Cohort Studies; Dose-Response Relationship, Drug; Female; Hospital Mortality; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Multivariate Analysis; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2014 |
Fever and abdominal pain following incision and drainage of a cutaneous abscess.
Topics: Abdominal Pain; Abscess; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Child, Preschool; Drainage; Fever; Humans; Kidney; Kidney Diseases; Male; Pyelonephritis; Staphylococcus aureus; Tomography, X-Ray Computed; Vancomycin | 2015 |
Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Chi-Square Distribution; Cooperative Behavior; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Incidence; Japan; Kidney Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Patient Care Team; Pharmacists; Pharmacy Service, Hospital; Professional Role; Program Evaluation; Retrospective Studies; Risk Assessment; Risk Factors; Staphylococcal Infections; Time Factors; Vancomycin | 2015 |
Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
Topics: Adolescent; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Empirical Research; Female; Humans; Kidney Diseases; Male; Retrospective Studies; Vancomycin | 2015 |
Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Incidence; Kidney Diseases; Male; Middle Aged; Pharmacists; Pharmacy Service, Hospital; Pilot Projects; Quality Assurance, Health Care; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2015 |
Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Drug Dosage Calculations; Female; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Sepsis; Vancomycin | 2015 |
Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Weight; China; Female; Humans; Incidence; Kidney; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2015 |
[Vancomycin intoxication in a patient with inappropriate antidiuretic hormone syndrome and diarrhea].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Diarrhea; Humans; Inappropriate ADH Syndrome; Kidney Diseases; Male; Vancomycin | 2015 |
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Diarrhea; Fidaxomicin; Humans; Kidney Diseases; Neoplasms; Quality-Adjusted Life Years; Spain; Treatment Outcome; Vancomycin | 2015 |
Methicillin-Resistant Staphylococcus aureus-Related Henoch-Schönlein Purpura Treated Without Systemic Immunosuppressants.
Topics: Abscess; Anti-Bacterial Agents; Humans; IgA Vasculitis; Kidney Diseases; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Creatinine; Female; Humans; Infant; Kidney Diseases; Male; Retrospective Studies; Vancomycin | 2015 |
High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients.
Topics: Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Emergency Service, Hospital; Humans; Incidence; Kidney Diseases; Patient Admission; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Increased Vancomycin Exposure and Nephrotoxicity in Children: Therapeutic Does Not Mean Safe.
Topics: Anti-Bacterial Agents; Child; Humans; Kidney Diseases; Vancomycin | 2016 |
Pre-Treatment Serum C-Reactive Protein Level Is An Independent Risk Factor for Development of Nephrotoxicity in Patients Receiving High-Dose Vancomycin.
Topics: Adult; Anti-Bacterial Agents; C-Reactive Protein; Female; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Vancomycin | 2016 |
Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Hyperbaric Oxygenation; Kidney; Kidney Diseases; Kidney Function Tests; Magnesium; Male; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Vancomycin | 2016 |
Application of vancomycin in patients with varying renal function, especially those with augmented renal clearance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2016 |
Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.
Topics: Anti-Bacterial Agents; Asian People; Child, Preschool; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Intensive Care Units; Kidney Diseases; Male; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Vancomycin | 2016 |
Vancomycin-Associated Cast Nephropathy.
Topics: Anti-Bacterial Agents; Female; Humans; Kidney Diseases; Middle Aged; Uromodulin; Vancomycin | 2017 |
Vancomycin in the Kidney-A Novel Cast Nephropathy.
Topics: Humans; Kidney; Kidney Diseases; Vancomycin | 2017 |
Assessment of vancomycin use in chronic haemodialysis patients: room for improvement.
Topics: Anti-Bacterial Agents; Catheters, Indwelling; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Male; Outcome Assessment, Health Care; Renal Dialysis; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chronic Disease; Daptomycin; Drug Resistance, Bacterial; Fatal Outcome; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2009 |
[Frequency of decreased renal function between patients treated with brand and generic products of vancomycin hydrochloride injection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Creatinine; Drugs, Generic; Female; Humans; Injections; Kidney Diseases; Kidney Function Tests; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2008 |
Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates.
Topics: Alkaline Phosphatase; Analysis of Variance; Animals; Anti-Bacterial Agents; Biomarkers; Blood Urea Nitrogen; Cluster Analysis; Female; gamma-Glutamyltransferase; Gene Expression; Inflammation; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Kidney Diseases; Mice; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Signal Transduction; Vancomycin | 2009 |
Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Female; Humans; Japan; Kidney Diseases; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Staphylococcal Infections; Tissue Distribution; Vancomycin | 2009 |
Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Female; Gram-Positive Bacterial Infections; Humans; Inpatients; Kidney; Kidney Diseases; Male; Middle Aged; New York; Plasma; Retrospective Studies; Time Factors; Vancomycin | 2009 |
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Enterocolitis; Fatal Outcome; Female; Humans; Imipenem; Kidney Diseases; Neurotoxicity Syndromes; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2009 |
Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Cardiac Surgical Procedures; Creatinine; Critical Care; Critical Illness; Cross Infection; Female; Hemofiltration; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Vancomycin; Young Adult | 2009 |
Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Biomarkers; Blood Urea Nitrogen; Body Weight; Creatine; Isoquinolines; Kidney; Kidney Diseases; Male; Organ Size; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolines; Rats; Rats, Wistar; Vancomycin | 2010 |
Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Humans; Kidney Diseases; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
A new forum for brief research reports in AJKD.
Topics: Anti-Bacterial Agents; Biomedical Research; Correspondence as Topic; Drug Administration Schedule; Glomerular Filtration Rate; Humans; Kidney Diseases; Periodicals as Topic; Pharmacokinetics; Publishing; Renal Dialysis; Vancomycin | 2010 |
Protective role of curcumin in nephrotoxic oxidative damage induced by vancomycin in rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Curcumin; Free Radicals; Kidney Diseases; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vancomycin | 2012 |
Clinical and serological diagnoses of a patient with vancomycin-induced thrombocytopenia.
Topics: Adenocarcinoma; Aged; Antibodies, Immobilized; Bacterial Infections; Colonic Neoplasms; Erythrocyte Transfusion; Fatal Outcome; Fluorescent Antibody Technique; Humans; Kidney Diseases; Male; Multiple Organ Failure; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Postoperative Complications; Rectal Neoplasms; Thrombocytopenia; Thrombosis; Vancomycin | 2011 |
Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.
Topics: Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Kidney Diseases; Obesity, Morbid; Vancomycin | 2012 |
Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bias; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Obesity; Practice Guidelines as Topic; Prospective Studies; Software; Time Factors; Vancomycin; Young Adult | 2011 |
Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Fever; Guideline Adherence; Hospitals, University; Humans; Inappropriate Prescribing; Induction Chemotherapy; Infusions, Intravenous; Kidney Diseases; Leukemia, Myeloid; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Biomarkers; Chi-Square Distribution; Creatinine; Databases as Topic; Female; Humans; Incidence; Intensive Care Units; Kaplan-Meier Estimate; Kidney Diseases; Logistic Models; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Vancomycin | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Creatine; Drug Dosage Calculations; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Models, Biological; Vancomycin | 2012 |
Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Biomarkers; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Kidney Diseases; Male; Puromycin; Rats; Rats, Wistar; Toxicity Tests, Subacute; Vancomycin; Xenobiotics | 2012 |
Continuation of high-dose vancomycin despite nephrotoxicity.
Topics: Anti-Bacterial Agents; Female; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2012 |
Performance of a vancomycin dosage regimen developed for obese patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Male; Middle Aged; Obesity; Retrospective Studies; Vancomycin | 2012 |
The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Female; Humans; Hypotension; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Vancomycin; Veterans | 2012 |
Aminoglycoside nephrotoxicity: modeling, simulation, and control.
Topics: Adult; Algorithms; Amikacin; Anti-Bacterial Agents; Area Under Curve; Circadian Rhythm; Computer Simulation; Creatinine; Female; Humans; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Male; Models, Biological; Vancomycin | 2003 |
Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity.
Topics: Adult; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Intensive Care Units; Kidney Diseases; Male; Middle Aged; Models, Economic; Oncology Service, Hospital; Retrospective Studies; Vancomycin | 2003 |
Staphylococcal septicaemia treated with vancomycin in the presence of chronic renal failure.
Topics: Anti-Bacterial Agents; Bacteremia; Kidney Diseases; Kidney Failure, Chronic; Sepsis; Staphylococcal Infections; Vancomycin | 1960 |
TOXICITY OF ANTIBIOTICS OTHER THAN PENICILLIN.
Topics: Anti-Bacterial Agents; Bacitracin; Bone Marrow Diseases; Drug Eruptions; Gastrointestinal Diseases; Kanamycin; Kidney Diseases; Liver Diseases; Necrosis; Neomycin; Neurologic Manifestations; Penicillins; Pharmacology; Polymyxins; Ristocetin; Streptomycin; Tetracycline; Toxicology; Vancomycin; Vestibule, Labyrinth | 1965 |
In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Topics: Acetylglucosaminidase; Administration, Oral; Animals; Anti-Bacterial Agents; Catalase; Disease Models, Animal; Drug Antagonism; Drug Therapy, Combination; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Tubules; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Thioglycolates; Thiophenes; Vancomycin | 2005 |
New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment.
Topics: Aged; Aged, 80 and over; Female; Humans; Kidney Diseases; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2005 |
Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity.
Topics: Amrinone; Animals; Anti-Bacterial Agents; Antioxidants; Female; Free Radicals; Ginkgo biloba; Glutathione Peroxidase; Kidney Cortex; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Melatonin; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Thioctic Acid; Vancomycin | 2005 |
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Creatine; Critical Illness; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Vancomycin | 2006 |
Nephrotoxicity of vancomycin in patients with normal serum creatinine.
Topics: Anti-Bacterial Agents; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Reference Values; Retrospective Studies; Vancomycin | 2006 |
The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomycin-induced nephrotoxicity in rats.
Topics: Animals; Antioxidants; CD13 Antigens; Creatinine; Cyclic N-Oxides; Drug Interactions; gamma-Glutamyltransferase; Histocytochemistry; Hydroxybenzoates; Iron Chelating Agents; Kidney Diseases; L-Lactate Dehydrogenase; Male; Random Allocation; Rats; Rats, Wistar; Spin Labels; Urea; Vancomycin | 2007 |
Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Drug Therapy, Combination; Female; Gestational Age; Humans; Hypokalemia; Hypophosphatemia; Iatrogenic Disease; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Kidney Diseases; Kidney Tubules; Male; Retrospective Studies; Vancomycin | 2007 |
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply | 2007 |
An unusual case of acute kidney injury due to vancomycin lessons learnt from reliance on eGFR.
Topics: Adult; Anti-Bacterial Agents; Creatinine; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Nephrology; Time Factors; Vancomycin | 2007 |
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Female; Humans; Kidney; Kidney Diseases; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Staphylococcus aureus; Vancomycin | 2007 |
Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Blood Urea Nitrogen; Catalase; Creatinine; Disease Models, Animal; Epoetin Alfa; Erythropoietin; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Recombinant Proteins; Superoxide Dismutase; Vancomycin | 2007 |
Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure.
Topics: Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Generic; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Male; Nephrectomy; Rats; Rats, Sprague-Dawley; Vancomycin | 2007 |
Validation of putative genomic biomarkers of nephrotoxicity in rats.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacitracin; Cisplatin; Gene Expression; Gene Expression Profiling; Genetic Markers; Gentamicins; Kidney; Kidney Diseases; Liver; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Toxicogenetics; Vancomycin | 2008 |
Early renal injury after myeloablative cord blood transplantation in adults.
Topics: Adult; Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Neoplasms; Humans; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Vancomycin; Whole-Body Irradiation | 2008 |
Lysostaphin in experimental renal infections.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Kanamycin; Kidney Diseases; Kidney Function Tests; Lincomycin; Lysostaphin; Mice; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1967 |
Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.
Topics: Adolescent; Adult; Aged; Child; Drug Administration Schedule; Female; Humans; Kidney; Kidney Diseases; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Renal Dialysis; Vancomycin | 1981 |
Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Vancomycin | 1984 |
Pharmacokinetics of vancomycin in patients with various degrees of renal function.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Half-Life; Humans; Kidney Diseases; Kinetics; Male; Middle Aged; Vancomycin | 1984 |
Hearing loss in end-stage renal disease - effect of dialysis.
Topics: Furosemide; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Renal Dialysis; Vancomycin | 1980 |
Vancomycin serum concentration monitoring: a continued debate.
Topics: Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Humans; Kidney Diseases; Liability, Legal; Renal Dialysis; Vancomycin | 1994 |
Vancomycin levels: to monitor or not to monitor.
Topics: Drug Monitoring; Humans; Kidney Diseases; Vancomycin | 1995 |
Why monitor peak vancomycin concentrations?
Topics: Drug Monitoring; Ear Diseases; Humans; Infusions, Intravenous; Kidney Diseases; Vancomycin | 1995 |
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient.
Topics: Adolescent; Adult; Aged; Aging; Bayes Theorem; Female; Fluorescence Polarization Immunoassay; Half-Life; Hospitalization; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Regression Analysis; Retrospective Studies; Risk Factors; Vancomycin | 1994 |
Plasma levels of piperacillin and vancomycin used as prophylaxis in liver transplant patients.
Topics: Adolescent; Adult; Aged; Bile; Chromatography, High Pressure Liquid; Female; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Piperacillin; Premedication; Vancomycin | 1993 |
Control of endemic glycopeptide-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Male; Middle Aged; Prevalence; Prospective Studies; Vancomycin | 1996 |
Interference with vancomycin fluorescence polarisation immunoassay in a nonuraemic patient.
Topics: Anti-Bacterial Agents; Cross Reactions; Enzyme Multiplied Immunoassay Technique; Fluorescence Polarization Immunoassay; Humans; Kidney Diseases; Male; Middle Aged; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1997 |
Dosage adjustment of antiinfective therapy in patients with renal impairment.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Vancomycin | 1997 |
Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
Topics: Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Cilastatin; Creatinine; Dose-Response Relationship, Drug; Drug Interactions; Kidney; Kidney Diseases; Male; Organ Size; Protease Inhibitors; Rabbits; Vancomycin | 1997 |
Abbott AxSYM Vancomycin II assay: multicenter evaluation and interference studies.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Drug Contamination; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Fluorescence Polarization Immunoassay; Humans; In Vitro Techniques; Infections; Kidney Diseases; Kidney Transplantation; Linear Models; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Vancomycin | 1998 |
[Nursing care plans for renal hospitalized patients infected with antibiotic resistant enterococci].
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Patient Care Planning; Vancomycin | 1998 |
Quantitation of vancomycin and its crystalline degradation product (CDP-1) in human serum by high performance liquid chromatography.
Topics: Cefazolin; Cephalosporins; Chromatography, High Pressure Liquid; Crystallization; Humans; Isomerism; Kidney Diseases; Reference Standards; Vancomycin | 1998 |
Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Infection Control; Kidney Diseases; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Scotland; Vancomycin | 1998 |
Toxicity of single daily dose gentamicin in stem cell transplantation.
Topics: Adult; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Hearing Disorders; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin | 1999 |
Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Colony Count, Microbial; Critical Care; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Units; Humans; Kidney Diseases; Mass Screening; Oncology Service, Hospital; Outcome Assessment, Health Care; Penicillins; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Vancomycin; Victoria | 1999 |
The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bone Marrow Transplantation; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Transplantation, Homologous; Vancomycin | 2000 |
[Examination of factors affecting efficacy and adverse effect, for the retrospective study of vancomycin hydrochloride (VCM)].
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Kidney Diseases; Liver Diseases; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Therapeutic Equivalency; Treatment Outcome; Vancomycin | 2001 |
Evaluation of Bayesian predictability of vancomycin concentration in patients with various degrees of renal function.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Drug Evaluation; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Models, Biological; Vancomycin | 2001 |
The effect of fosfomycin on glycopeptide antibiotic-induced nephrotoxicity in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fosfomycin; Gentamicins; Histocytochemistry; Kidney; Kidney Diseases; Male; Rats; Rats, Wistar; Teicoplanin; Vancomycin | 2001 |
Cost perspectives for outpatient intravenous antimicrobial therapy.
Topics: Anti-Bacterial Agents; Cohort Studies; Data Collection; Exanthema; Fee-for-Service Plans; Fever; Home Infusion Therapy; Humans; Infusions, Intravenous; Infusions, Parenteral; Insurance, Health, Reimbursement; Kidney Diseases; Managed Care Programs; Medicaid; Medicare; Practice Patterns, Physicians'; Retrospective Studies; United States; Vancomycin | 2002 |
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment.
Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Methotrexate; Osteosarcoma; Vancomycin | 2002 |
The nephrotoxicity of antimicrobial agents (second of three parts).
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Glomerular Filtration Rate; Guinea Pigs; Half-Life; Humans; Kidney; Kidney Diseases; Polymyxins; Rabbits; Rats; Tetracyclines; Vancomycin | 1977 |
Exchange transfusion and multidose activated charcoal following vancomycin overdose.
Topics: Charcoal; Creatinine; Drug Overdose; Ear Diseases; Exchange Transfusion, Whole Blood; Half-Life; Humans; Infant; Kidney Diseases; Male; Vancomycin | 1992 |
Vancomycin half-life in a patient with hepatic and renal dysfunction.
Topics: Aged; Half-Life; Humans; Kidney Diseases; Liver Diseases; Male; Metabolic Clearance Rate; Vancomycin | 1991 |
Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats.
Topics: Animals; Daptomycin; Drug Interactions; Female; Kidney Cortex; Kidney Diseases; Kidney Medulla; Peptides; Rats; Rats, Inbred Strains; Sphingomyelin Phosphodiesterase; Thymidine; Tobramycin; Vancomycin | 1990 |
Vancomycin in resistant hepatic encephalopathy.
Topics: Hepatic Encephalopathy; Humans; Kidney Diseases; Vancomycin | 1990 |
Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoass
Topics: Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Humans; Immunoenzyme Techniques; Kidney Diseases; Vancomycin; Vitamin B 12 | 1990 |
Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
Topics: Adult; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Vancomycin | 1990 |
High-level vancomycin-resistant enterococci causing hospital infections.
Topics: Acute Kidney Injury; Conjugation, Genetic; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Humans; Kidney Diseases; R Factors; Streptococcal Infections; Streptococcus; Vancomycin | 1989 |
[Value of enzymuria during antibacterial therapy].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; Bacterial Infections; CD13 Antigens; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; gamma-Glutamyltransferase; Hexosaminidases; Humans; Kidney; Kidney Diseases; Middle Aged; Netilmicin; Urea; Vancomycin | 1989 |
Potential problem with fluorescence polarization immunoassay cross-reactivity to vancomycin degradation product CDP-1: its detection in sera of renally impaired patients.
Topics: Chromatography, High Pressure Liquid; Cross Reactions; Fluorescence Polarization; Humans; Immunoassay; Immunoenzyme Techniques; Kidney Diseases; Molecular Weight; Radioimmunoassay; Time Factors; Vancomycin | 1989 |
Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant?
Topics: Blood Urea Nitrogen; Creatinine; Female; Fetal Blood; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Kidney Diseases; Milk, Human; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Staphylococcal Infections; Vancomycin | 1989 |
Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides.
Topics: Adult; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Kidney Diseases; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Sodium; Statistics as Topic; Ticarcillin; Vancomycin | 1988 |
Vancomycin pharmacokinetics in patients with various degrees of renal function.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Vancomycin | 1988 |
Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Kidney Diseases; Prospective Studies; Vancomycin | 1987 |
Routine monitoring of serum vancomycin concentrations: waiting for proof of its value.
Topics: Drug Administration Schedule; Drug Therapy; Ear Diseases; Humans; Kidney Diseases; Vancomycin | 1987 |
Vancomycin enhancement of experimental tobramycin nephrotoxicity.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Drug Synergism; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred F344; Tobramycin; Vancomycin | 1986 |
Disposition of vancomycin during hemofiltration.
Topics: Aged; Female; Humans; Kidney Diseases; Kinetics; Male; Middle Aged; Ultrafiltration; Vancomycin | 1986 |
Nephrotoxicity of vancomycin-gentamicin therapy in pediatric patients.
Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Kidney Diseases; Male; Vancomycin | 1987 |
[Therapeutic progress: vancomycin].
Topics: Clostridium Infections; Drug Hypersensitivity; Humans; Kidney Diseases; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1985 |
A prospective study of adverse reactions associated with vancomycin therapy.
Topics: Adolescent; Adult; Aged; Child; Corynebacterium; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Hearing Disorders; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Staphylococcus aureus; Staphylococcus epidermidis; Thrombophlebitis; Vancomycin | 1985 |
Vancomycin/aminoglycoside nephrotoxicity.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Gentamicins; Humans; Infant; Infant, Newborn; Kidney Diseases; Vancomycin | 1985 |
[Elimination of antibiotics and sulfonamides from the human organism during renal insufficiency and the therapeutic consequences].
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Chloramphenicol; Creatinine; Dicloxacillin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Methicillin; Novobiocin; Oxacillin; Penicillin G; Penicillins; Polymyxins; Streptomycin; Sulfonamides; Tetracycline; Vancomycin | 1969 |
Comparison of treatments with several antibiotics in experimental infections due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Drug Synergism; Kanamycin; Kidney; Kidney Diseases; Male; Methicillin; Penicillin Resistance; Rats; Staphylococcal Infections; Staphylococcus; Vancomycin | 1972 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
[Kinetic specification of some antibiotics in cases with kidney insufficiency].
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalosporins; Chloramphenicol; Erythromycin; Gentamicins; Humans; Kanamycin; Kidney Diseases; Oxacillin; Penicillins; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Influence of the renal function on the pharmacokinetics of various drugs].
Topics: Anti-Bacterial Agents; Anuria; Colistin; Gentamicins; Glomerular Filtration Rate; Half-Life; Humans; Kidney; Kidney Diseases; Rolitetracycline; Streptomycin; Tetracycline; Vancomycin | 1972 |
[Antibiotic therapy in disturbed kidney function].
Topics: Ampicillin; Anti-Bacterial Agents; Cephaloridine; Cephalothin; Creatinine; Erythromycin; Gentamicins; Glomerular Filtration Rate; Humans; Kanamycin; Kidney Diseases; Kidney Function Tests; Lincomycin; Oxacillin; Penicillin G; Streptomycin; Tetracycline; Vancomycin | 1971 |
Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis.
Topics: Acute Kidney Injury; Adult; Humans; Kidney Diseases; Kidneys, Artificial; Staphylococcal Infections; Vancomycin | 1966 |